The consequences of cerebrovascular disease are among the leading health issues worldwide. Large and small cerebral vessel disease can trigger stroke and contribute to the vascular component of other forms of neurological dysfunction and degeneration. Both forms of vascular disease are driven by diverse risk factors, with hypertension as the leading contributor. Despite the importance of neurovascular disease and subsequent injury after ischemic events, fundamental knowledge in these areas lag behind our current understanding of neuroprotection and vascular biology in general. The goal of this review is to address select key structural and functional changes in the vasculature that promote hypoperfusion and ischemia, while also affecting the extent of injury and effectiveness of therapy. In addition, as damage to the blood-brain barrier is one of the major consequences of ischemia, we discuss cellular and molecular mechanisms underlying ischemia-induced changes in blood-brain barrier integrity and function, including alterations in endothelial cells and the contribution of pericytes, immune cells, and matrix metalloproteinases. Identification of cell types, pathways, and molecules that control vascular changes before and after ischemia may result in novel approaches to slow the progression of cerebrovascular disease and lessen both the frequency and impact of ischemic events. (Circ Res. 2017;120:449-471.
T he consequences of cerebrovascular disease are among the leading health issues worldwide. 1, 2 Although ischemic stroke is perhaps the best known end-organ effect, diseases of the cerebral circulation are a major contributor to hemorrhagic stroke, dementias (Alzheimer disease and vascular dementia) and other forms of neurological dysfunction and degeneration. [3] [4] [5] Ischemic stroke is primarily a consequence of carotid and cerebrovascular disease, the latter of which includes both large vessel disease and small-vessel disease (SVD). In addition to larger ischemic strokes produced by thrombosis in carotid or cerebral arteries, hemorrhagic stroke can also occur. Microvascular changes during SVD result in small regions of ischemia and microbleeds (microhemorrhages). 6, 7 Once initiated, both large vessel disease and SVD typically progress slowly over a period of many years. This rate of progression and the frequency of large and small ischemic events and microbleeds is accelerated during aging and in the presence of vascular risk factors (Figure 1 ). In addition, disease modifiers like genetics or diet can reduce or increase the rate of progression of vascular disease and events in brain ( Figure 1 ).
This review is organized into 2 interrelated sections. First, we highlight functional and structural changes in the vasculature that affect cerebral blood flow (CBF) and adaptive vascular responses in ways that promote hypoperfusion, underlie ischemic events, and are determinants of the extent of ischemic-induced injury. Examples of common underlying mechanisms of vascular disease are presented. Second, changes in the blood-brain barrier (BBB) and components of the neurovascular unit (NVU) are integrated elements of this pathophysiology. Recent insight into cellular and molecular mechanisms that underlie vascular and nonvascular injury and repair after ischemia with or without reperfusion (I/R) are presented with an emphasis on BBB, pericytes, inflammatory cells, along with related molecules. The impact of other NVU components, such as astrocytes, has been extensively reviewed elsewhere. 8, 9 Part I. Cerebrovascular Disease:
The Prelude to Stroke
Overview of Mechanisms That Control CBF
Several major mechanisms contribute to regulation of CBF. Collectively, these mechanisms determine baseline CBF and underlie adjustments in perfusion that occur acutely (from seconds to minutes) and chronically (from months to years) in response to physiological and pathophysiological conditions. To begin, we provide an overview of such mechanisms, each of which is affected by vascular disease and ischemic events.
Vascular Endothelium
The impact of endothelial cells in health and disease should not be underestimated. These cells are the site of the BBB and thus have a major role in controlling the movement of ions, molecules, and cells into and out of the brain. 10, 11 Endothelium determines the thromboresistance property of vessels via antiplatelet, antithrombotic, and fibinolytic mechanisms. 12, 13 Through various intrinsic mechanisms, endothelial cells are normally in a state that suppresses proinflammatory gene expression, recruitment of monocytes, and development of atherosclerosis. [14] [15] [16] Endothelium-dependent effects on underlying smooth muscle are a major regulator of vessel tone. Two primary mechanisms are involved-production and release of vasoactive molecules that diffuse to specific molecular targets and endothelium-dependent hyperpolarization of vascular muscle. [16] [17] [18] Through these mechanisms, endothelial cells affect resting CBF and mediate vasodilator responses to shear stress, neurotransmitters, metabolic factors, and therapeutic agents. 16, 17 An even broader impact of endothelial cells becomes apparent when their influence on amyloid precursor protein, amyloid β, and phosphorylation of tau (critical for the pathogenesis of Alzheimer disease) is taken into account. 19, 20 In addition, endothelium affects the function of various nonvascular cells including neurons, microglia, and oligodendrocytes. 17, 19, 21 Although not the only mechanism involved, most of these effects are mediated through nitric oxide (NO) produced by endothelial NO synthase (eNOS; Figure 2 ). 12, 13, 16, 17, 19, 20, 22, 23 
Neurovascular Coupling
The process by which changes in neural activity elicit proportional and spatially controlled changes in CBF is often referred to as neurovascular coupling (NVC; or functional hyperemia). Some common tools in neuroscience, such as functional magnetic resonance imaging, are based on changes in hemodynamics during the NVC response. 24 This response involves a network of coordinated cells and signaling events that have neuronal activation at its core, with integrated contributions by astrocytes and endothelial cells. 25, 26 Astrocytes make cellular contacts with vascular muscle in a heterogeneous pattern depending on brain region (relatively high in striatum, much lower in cerebral cortex). 27 Signaling between neurons, astrocytes, and vascular cells involves a family of molecules (NO, K + , adenosine, and prostanoids) that may vary with cell type and brain region. 24, 28 Pericytes may be involved as well, but their role in NVC is controversial. 22 29 but other studies do not support this concept. [30] [31] [32] 
Autoregulation
The ability of the brain to maintain a relatively constant level of CBF over a range of perfusion pressures is well described and typically referred to as autoregulation. 18, 33 Of the various mechanisms involved, myogenic function of resistance vessels is generally considered the most important. These mechanisms contribute to autoregulation in that vessels constrict when intravascular (transmural) pressure is increased and dilate when intravascular pressure is reduced. 18 This basic feature is present in vessels from animals models and humans. 18, 22, [34] [35] [36] When studied in vitro, myogenic tone (generated when a vessel is pressurized) and myogenic responses (changes in tone with changes in transmural pressure) are often differentiated. 18 The myogenic response is an intrinsic property of vascular muscle, 18, 36 but can be modulated by other cell types. Although widely studied in isolated arteries, our understanding of its mechanistic basis is still fragmented, particularly in relation to what actually senses changes in transmural pressure. Simply stated, increases in pressure produce depolarization of vascular muscle, likely via activation of transient receptor potential channels, resulting in increases in intracellular calcium and contraction. 18 As discussed below, myogenic mechanisms can change in disease. 18 For example, the relationship of CBF to perfusion pressure, presented as the autoregulatory curve, normally shifts to the right (to higher levels of pressure) during chronic hypertension. With such a shift, the brain can be at risk for reductions in CBF and injury during decreases in perfusion pressure, such as that occurs with systemic hypotension or occlusion of upstream vessels during ischemia.
Vascular Risk Factors
To a great extent, stroke is a disease of the aged. The rate of vascular events including stroke increases markedly with age. [37] [38] [39] The latest global analysis indicates that men have a higher incidence of ischemic and hemorrhagic stroke than age-matched women. 39 Chronic hypertension has been and continues to be a leading risk factor for vascular disease and ischemic and hemorrhagic stroke. 1, 38, 40, 41 For reasons that are not clear, hypertension is a greater risk factor for stroke than it is for myocardial infarction. 40 Although some risk factors vary geographically in their impact, hypertension is the leading risk factor for stroke regardless of region. 41 Other key risk factors for stroke are dietary (diets high in salt, low in fruits, and whole grains), metabolic (elevated fasting glucose and body mass index), behavioral (smoking and low physical activity), and environmental (air pollution; Figure 1 ). 41 Collectively these specific risk factors account for >90% of all strokes. 41 
Large Vessel Disease Versus SVD
Cerebrovascular disease is often discussed in terms of large vessel disease and SVD. In this context, small vessels refer to those on the brain surface and within the parenchyma, including smaller arteries, arterioles, capillaries, and venules. 7, 42 Large vessel disease and SVD share not only common features but also have unique characteristics. In this section, we highlight some specific examples and concepts related to large and small blood vessels.
The brain is unique in relation to the distribution of vascular resistance. When small arterioles in the pial circulation are taken as a reference point, roughly half of vascular resistance resides in arterioles and arteries upstream, the other half is downstream within the circulation of the parenchyma. 22, 33 Although the BBB is present throughout the cerebral circulation, it has heterogeneous features. [43] [44] [45] Capillaries often receive much of the focus, but many of the interactions between the BBB and immune cells, 44 along with dynamic changes in the integrity of tight junctions (TJ) in response to ischemia occur at the level of small venules. 46 Although both arteries and arterioles display myogenic function, the degree of myogenic tone developed is related to vessel size. For example, isolated parenchymal arterioles develop greater myogenic tone than the middle cerebral artery. 34, [47] [48] [49] [50] Small pial arterioles have substantial tone in vivo, [51] [52] [53] [54] [55] [56] greater than that present in larger vessels within the same network. 57, 58 Through its molecular targets, eNOS influences tone in large arteries to the smallest parenchymal arterioles. 17, 22, 34 In contrast, endothelium-dependent hyperpolarization that involves small and intermediate conductance K + channels and myoendothelial gap junctions have more prominent effects in small arterioles. 17, 22, 34 As discussed below, changes in vascular mechanics and structure during disease can also differ in large versus small vessels.
Vascular regulation requires integration between large and small vessels. For example, both pial and parenchymal arterioles dilate during NVC. 24, 25, 31, 59 Because resistance of large arteries is relatively high in brain, 22, 33 an absence of upstream vasodilation would result in reductions in local microvascular (perfusion) pressure during NVC or with other stimuli that reduce small vessel resistance. 22, 33, 60 Although both conducted and flow-mediated responses may be involved in vivo, mechanisms that control this integration is one of the least understood areas of vascular control. Endothelial cells sense shear stress 16, 17 and are responsible for propagation of vasodilation during NVC, through mechanisms that have yet to be defined. 25 
Endothelial Dysfunction: Putting the Brain at Risk
Considering the broad impact of this cell, it is no surprise that loss of endothelial health represents a cornerstone event in the pathogenesis of vascular disease, and as a consequence, brain health (Figures 1 and 2) . 17, 19, 22 Endothelial-based abnormalities reside center stage in relation to cerebrovascular disease, stroke onset, neurovascular injury, and repair. These changes in endothelium promote oxidative stress, low-grade inflammation, increased vascular tone, loss of BBB integrity, atherosclerosis, and thrombosis. Collectively, such changes are often referred to as endothelial dysfunction. 17, 23, 61 Because a portion of the response is endothelium dependent, endothelial dysfunction contributes to loss of NVC as well. In relation to long-term effects on brain health, reductions in NVC are thought to contribute to cellular injury and degeneration over time. However, the relative importance of baseline hypoperfusion versus reductions in NVC per se is not known. 62 Disruption in the endothelial control of vascular tone is predictive of cardiovascular events including stroke in animals and humans. 16 ), calmodulin (CaM), and tetrahydrobiopterin (BH 4 ) and is inhibited by caveolin-1. eNOS-mediated effects in healthy endothelium is show in the upper right. The bottom of the figure highlights major mechanisms that contribute to endothelial dysfunction, including the renin-angiotensin-aldosterone systems (RAAS), oxidative stress, asymmetrical dimethylarginine (ADMA), and Rho kinase (see text for additional details). ACE indicates angiotensin-converting enzyme; Aldo, aldosterone; APP, amyloid precursor protein; AT1R, AT1 receptor; DDAH, dimethylarginine dimethylaminohydrolase; ET1R, endothelin-1 receptor; GPx, glutathione peroxidase; Mito, mitochondria; MR, mineralocorticoid receptor; NF-κB, nuclear factor-κB; O 2 − , superoxide; NVC, neurovascular coupling; ONOO − , peroxynitrite; ox-LDL, oxidized low-density lipoprotein; and SOD, superoxide dismutase.
How does endothelial dysfunction, often first detected based on changes in vascular tone, evolve and translate to more severe disease and ultimately ischemic events? Multiple mechanisms are now known to contribute. One key effect of eNOS-derived NO is suppression of atherosclerosis.
14 This phenotype results from inhibitory effects of NO on platelets, expression of adhesion molecules with recruitment of monocytes, formation of oxidized low-density lipoproteins (ox-LDL) and isoprostanes, and activation of nuclear factor-κB ( Figure 2) . 15, 61 Beyond their role in hemostasis, platelets and platelet-derived microparticles may contribute to the progression of atherosclerosis. 63 Platelet aggregation may be an early event in the pathogenesis of Alzheimer disease, 64, 65 as platelets promote aggregation of β-amyloid through integrin and chaperone-dependent mechanisms. 65 Regulation of eNOS and its signaling is complex, occurring at the level of transcription, post-translational modification, enzyme activity, NO bioavailability, and molecular targets of NO ( Figure 2) . 14, 16, 17, 66 Thus, abnormalities in this signaling network can occur at various levels. For example, genetic loss of eNOS augments atherogenesis in hyperlipidemic mice, 14 whereas partial genetic deficiency, when combined with age, results in formation of microthrombi in brain, BBB abnormalities, localized loss of perfusion, and cognitive deficits. 67 There are many examples of oxidant-dependent mechanisms, reactive oxygen species (ROS)-mediated loss of NO signaling, and other aspects of vascular disease. Some of these mechanisms are common to both endothelial dysfunction and dysregulation of NVC (Figure 2) . 3, 17, 22, 62 For example, superoxide-mediated oxidative stress impairs regulation of vascular tone and CBF in models of aging and major risk factors for stroke. 22 Oxidative stress can result from both increased production of superoxide or loss of antioxidant molecules that limit increases in superoxide (eg, superoxide dismutases; Figure 2 ). Major sources of superoxide in vascular cells include NADPH oxidases (Nox) and mitochondria ( Figure 2) . 68 Because superoxide reacts so efficiently with NO, the local concentration of superoxide is a determinant of the bioavailability of NO. In addition to NO, superoxide reacts with arachidonic acid forming isoprostanes. 69 Activation of thromboxane receptors by isoprostanes may contribute to atherosclerosis. 69, 70 Other downstream effects of superoxide that contribute to vascular dysfunction include formation of peroxynitrite (the reaction product of NO and superoxide; Figure 2 ) along with increased activity of ADP ribose polymerase and selective transient receptor potential channels. 22, 62, 71 Both local (organ-based) and circulating renin-angiotensin-aldosterone systems (RAAS; Figure 2 ) contribute to vascular disease including atherosclerosis. 17, [72] [73] [74] [75] [76] [77] [78] Angiotensin II (Ang II), a major effector peptide of the RAAS, produces oxidative stress, activation of nuclear factor-κB and low-grade inflammation in both large and small vessels. 17, 22, 71, [79] [80] [81] Many of the diverse effects of the RAAS are mediated by Ang II acting on AT1 receptors (AT1R; Figure 2) . 17, 76 Although less is known relative to Ang II, effects of aldosterone signaling via mineralocorticoid receptors on endothelium and smooth muscle have begun to emerge. 82, 83 Circulating aldosterone produces Nox2-dependent endothelial dysfunction without increasing arterial pressure ( Figure 2) . 84 In addition to detrimental effects, there is a protective arm of the RAAS. This includes the AT2 receptor, the angiotensin-converting enzyme 2 pathway, and angiotensin 1 to 7 acting on mas receptors. 76, 85 For example, activation of mas receptors produces NO-mediated endothelium-dependent vasodilation in cerebral arteries. 86 One of the mechanisms by which activity of eNOS and production of NO can be reduced is by formation and accumulation of methylated analogues of l-arginine including asymmetrical dimethylarginine, an inhibitor of NOS activity. 66, 87, 88 Cellular concentrations of asymmetrical dimethylarginine and effects on vessels are dependent, in part, on its hydrolysis by dimethylarginine dimethylaminohydrolases (Figure 2 ). 87 Interactions between asymmetrical dimethylarginine, Nox, and RAAS have been described. 89, 90 In patients, circulating levels of asymmetrical dimethylarginine positively correlate with the presence of intracranial atherosclerosis. 91 Through inhibitory effects on expression and activity of eNOS (and other mechanisms), Rho kinase (ROCK) promotes endothelial dysfunction, vasoconstriction, and progression of atherosclerosis. 92 Activation of RhoA and its target ROCK are required for Ang II-and endothelin-1-induced endothelial dysfunction and reduced NVC ( Figure 2) . 50, 93 Subsequent experiments revealed that the ROCK2 isoform of ROCK was essential for Ang II-induced endothelial dysfunction.
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Atherosclerosis and Hypercholesterolemia
Atherosclerosis
In relation to ischemic events and associated cognitive deficits, atherosclerosis is one of the most important forms of vascular disease. [94] [95] [96] Atherosclerosis begins in regions where endothelial dysfunction and local hemodynamics support a process that includes retention and modification of lipids, recruitment of monocytes, and other inflammatory cells, along with phenotypic switching of vascular muscle. 15 Atherosclerosis is primarily a disease of large arteries, 97 but can extend into smaller vessels with the addition of hypertension, 98 and perhaps other risk factors.
Intracranial atherosclerosis is a common cause of ischemic stroke, but a form of atherosclerosis with unique features. [94] [95] [96] In both animal models and humans, intracranial atherosclerosis develops at a slower rate than extracranial atherosclerosis. [94] [95] [96] Although fatty streaks (precursors of plaques) are present early in life, the number and size of these lesions are less in cerebral than in extracranial arteries. 99 Intracranial atherosclerosis progresses with age and is common in the elderly. 95, 96, 100, 101 Significant racial differences exist with cerebral atherosclerosis being more common in blacks, Hispanics, and Asians. [95] [96] [97] Its rate of progression is accelerated when combined with select risk factors that include hypertension and diabetes mellitus. 95, 96 A similar accelerating effect is seen in animals models. 98 The role of lipids and effects of tobacco smoking seem to be less for cerebral atherosclerosis compared with arteries outside the brain. 95, 96 There are also suggestions that sex differences may be less prominent with intracranial atherosclerosis.
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Advanced atherosclerosis can become stenotic, physically encroaching on the vessel lumen, 98 thus affecting downstream or collateral perfusion ( Figure 3 ). These lesions can also become unstable and rupture, with resulting vasoconstriction, platelet activation, and thrombosis. In addition to potential effects on hemodynamics and thrombosis, intracranial atherosclerosis has been linked to Alzheimer disease. 100, 102 For example, the more severe the extent of atherosclerosis, the lesser the performance over a range of cognitive domains and the greater risk for dementia. 100 Intracranial atherosclerosis may impact Alzheimer disease by contributing to not only hypoperfusion but also other mechanisms including increased processing of amyloid precursor protein and reduced clearance of β-amyloid. 103 Because it has pro-oxidant and proinflammatory effects, β-amyloid may also promote atherogenesis. 103 Why atherosclerosis develops more slowly in brain is not clear, but several possibilities might be considered. Mechanistic studies that focus on intracranial atherosclerosis are relatively rare, but it seems likely that fundamental differences in endothelial cells, recruitment of immune cells, and the balance between pro-and antiatherogenic mechanisms must exist. Pivotal transcription factors that determine the rate of atherosclerosis progression outside of brain include endothelial nuclear factor-κB and Kruppel-like factor 2. 15 Thus, differences between hemodynamics, key molecular integrators, and the impact of endothelium-derived NO may play major roles. Intracranial arteries may be less susceptible to hypercholesterolemia and ox-LDL, in part, because of differences in antioxidants, 99, 101 known to affect progression of experimental atherosclerosis. 104 In addition, the gut microbiota can affect the rate of progression of experimental atherosclerosis. 105, 106 Whether this or other microbiota affects intracranial atherosclerosis is unknown. Gut microbes can affect platelet responsiveness and clot formation, 107 important factors in hemostasis and thrombosis.
In relation to specific mechanisms, Ang II promotes atherosclerosis via the AT1R with downstream effects on plaque composition and stability. Atherosclerotic lesions express major components of the RAAS. 75 Genetic deficiency in AT1R results in reductions in lipid content, superoxide, immune cells, proinflammatory cytokines, and matrix metalloproteinase (MMP) activation within the vessel wall-effects that collectively result in smaller and more stable atherosclerotic plaques. 75, 108 Of note, the local RAAS contributes to the progression of atherosclerosis even in the absence of increases in plasma Ang II. 75 In addition to effects on atherosclerosis, AT1R deficiency decreases the rate of amyloid deposition and β-amyloid production in an Alzheimer disease model via effects on the γ-secretase complex.
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Hypercholesterolemia
Dietary and genetic models of hypercholesterolemia continue to be used to study effects of hyperlipidemia on the cerebral circulation. Several concepts have emerged from these efforts. Some studies found that endothelial function in cerebral arteries was normal in animals that exhibit atherosclerotic lesions and endothelial dysfunction in the carotid artery and aorta. [110] [111] [112] Acute treatment with ox-LDL impairs endothelium-dependent relaxation in the carotid but not in the basilar artery. 113 Thus, intracranial arteries can exhibit some resistance to ox-LDL and chronic hypercholesterolemia, experimental findings consistent with the delayed development of intracranial atherosclerosis. In other studies, hypercholesterolemia was sufficient to produce vascular dysfunction in animal models including primates. For example, in models where cerebral arteries had minimal or no detectable atherosclerotic lesions, hypercholesterolemia reduced resting CBF, the influence of basally produce NO on vascular tone, [114] [115] [116] as well as agonistand platelet-induced endothelium-dependent relaxation. [117] [118] [119] [120] Vasoconstrictor responses to endothelin-1 were substantially increased in hyperlipidemic mice. 117 There are limited data in this area in human vessels, but contraction of cerebral arteries in response to platelets and leukocytes is enhanced in vessels with atherosclerotic lesions. 121 In addition, other key vasodilator responses are reduced during hypercholesterolemia including NVC, effects of hypercapnia, and autoregulation of CBF. 116, 122 In the microcirculation, there are increased interactions between both leukocytes and platelets with endothelial cells. 123 Finally, hypercholesterolemia can affect pericytes and their interactions with endothelial cells 124 as well as producing age-dependent increases in BBB permeability. 125 Mechanisms that underlie cerebrovascular dysfunction with hypercholesterolemia are not well defined but include effects on NO signaling (Figure 2 ). There is evidence for decreased production of NO, with reduced phosphorylation of eNOS at Ser 1179 . 117 ROS and the Nox2-containing Nox have been implicated for several end points. 115, 118, 123, 125 ROCK can promote progression of atherosclerosis via several mechanisms including effects on Nox and eNOS (Figure 2) . 92 Expression of both ROCK1 and ROCK2 is increased in brain microvessels in hyperlipidemic mice. 126 A substantial reduction in expression of the nuclear receptor peroxisome proliferatoractivated receptor-γ (PPARγ) occurs during hypercholesterolemia. 126 PPARγ normally exerts protective effects in large and small blood vessels including promoting NO-dependent signaling while suppressing oxidative stress, superoxide-mediated endothelial dysfunction, inward vascular remodeling, and ROCK-mediated increases in vascular tone. 49, 54, 86, 127, 128 Consistent with a protective role, reduced levels of PPARγ in macrophages and vascular muscle are associated with more advanced atherosclerosis. 129 Genetic interference with PPARγ in endothelium or vascular muscle enhances atherosclerosis. 130 Despite these advances, there is a notable lack of studies using preclinical models that develop intracranial atherosclerosis. As a consequence, we have limited insight into mechanisms that control its pathogenesis. To better understand this form of atherosclerosis, new models may be needed. Current models of hyperlipidemia may still be useful if animals are allowed to age sufficiently to develop cerebral atherosclerosis, thus mimicking the natural progression of the disease. Incorporation of major risk factors for intracranial atherosclerosis like hypertension can have marked effects on disease severity. 98 Importantly, we also have limited insight into the functional impact of regression of intracranial atherosclerosis along with underlying mechanisms. The findings that the lipid content within the vessel wall and endothelial function in the internal carotid artery rapidly improve with dietary lipid lowering in a primate model of atherosclerosis suggest that regression may have substantial vascular effects. 131 
Vascular Structure and Mechanics
In addition to function, changes in the structural or mechanical state of the vasculature have a major influence on vascular resistance and local hemodynamics, the extent of injury once ischemia is initiated, and the effectiveness of collateraldependent CBF. During hypertension, for example, vascular resistance increases because of both narrowing of the vascular lumen and loss of vessels. Such changes are among those commonly seen in both large vessel disease and SVD. With time and the natural progression of disease, degeneration of cerebral arterioles occurs in humans and preclinical models. [132] [133] [134] [135] [136] Degeneration of the vessel wall and loss of BBB integrity promote passage of molecules out of the circulation along with microbleeds and reductions in microvascular density. 137, 138 Changes in vascular structure or distensibility can have important effects on resting CBF (hypoperfusion), vasodilator responses, and vasodilator capacity (Figure 3) . 3, 135, 136 Because this impairment can affect both submaximal and maximal vasodilation, 22, 55 key adaptive responses such as NVC, conducted or flow-dependent vasodilation, and autoregulation can each be impacted. In this section, we summarize select examples and key concepts related to changes in vascular structure and mechanics. 22, 35, 139 Vascular Hypertrophy Increases in the cross-sectional area of the vessel wall (referred to as hypertrophy here) represent an adaptive response to reduce wall stress during hypertension. Vascular hypertrophy is common, being present in genetic, renal, and pharmacological models of hypertension. 35, 52, [139] [140] [141] [142] [143] [144] Wall thickening is often described in cerebral arteries in humans with hypertension, particularly in the early phase of the disease. 138 In relation to its impact on vascular resistance, hypertrophy of the vessel wall during hypertension contributes to the reduction in lumen diameter that is present in maximally dilated vessels ( Figure 3) . 55, 142 Vascular hypertrophy is not unique to hypertension, however, occurring in models of hyperhomocysteinemia, oxidative stress, diabetes mellitus, and genetic interference with eNOS or PPARγ. 51, 53, 127, [145] [146] [147] In contrast, atrophy or thinning of the arteriolar wall occurs with aging, 148 a process that may contribute to the increased frequency of microbleeds with age.
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Vascular Remodeling
Remodeling is a term used by some to describe any structural change in the vasculature. Experts in the area argue that the term should be used specifically to describe changes in lumen diameter in fully dilated vessels that are not because of changes in wall stiffness or distensibility. 150 Thus, inward remodeling represents a rearrangement of the vessel wall such that lumen diameter is reduced even when the vessel is maximally dilated (Figure 3 ). Both vascular hypertrophy and inward remodeling occur during hypertension, the latter making the greatest contribution to the reduction in lumen diameter and therefore vascular resistance. 55, 142 Structural reductions in lumen diameter can have predictive value in relation to cardiovascular events. 151 Although detrimental hemodynamic effects are clear, the increase in vessel resistance that results from inward remodeling also protects distal vessels and the BBB from increases in upstream pressure. 152 Inward remodeling is seen most commonly in resistance vessels. It is present in both pial and parenchymal arterioles in some, 52, [140] [141] [142] [143] [144] 148, [153] [154] [155] [156] but not in all models of hypertension. 52, 140 Collectively, these findings and others 55 support the concept that Ang II is an important determinant of inward vascular remodeling. Further support for this concept comes from the observation that chronic infusion of a nonpressor dose of Ang II is sufficient to produce inward remodeling in cerebral arterioles. 143 In genetically hypertensive rats, inhibition of angiotensin-converting enzyme is more effective than other antihypertensives in lessening inward remodeling and impairment of vasodilation during reductions in arterial pressure. 55 In humans with essential hypertension, there is evidence that inward remodeling occurs in small cerebral arteries. [157] [158] [159] In some disease models, vascular hypertrophy is present, but not inward remodeling. 51, 53, 56, 145 An exception are models February 3, 2017
with genetic interference of PPARγ where both inward modeling and vascular hypertrophy occur. 127, 146 It is noteworthy that one of the pleiotropic effects of PPARγ is inhibition of expression and function of AT1R. 17, 128, 160 Thus, PPARγ interference mimics effects of Ang II. These studies highlight that loss of endogenous protective mechanisms is an additional cause of changes in vascular structure.
Some mechanistic features that underlie these changes have emerged. Oxidative stress or loss of eNOS-derived NO, in the absence of hypertension or Ang II, fail to produce inward vascular remodeling. 51, 53 The pattern differs when Ang II is involved. Inward arteriolar remodeling in response to nonpressor and pressor doses of Ang II requires normal expression of Nox2. 143 In addition to activation of AT1R, Ang II transactivates epidermal growth factor receptor via a disintegrin and metalloprotease 17 intermediate. 161 Ang II produces phosphorylation of epidermal growth factor receptor in cerebral arterioles, whereas pharmacological or genetic inhibition of epidermal growth factor receptor prevents Ang II-induced hypertrophy, but not inward remodeling. 153 Many of the signaling molecules associated with AT1R and epidermal growth factor receptor are localized in caveolae. 161 Ang II increases vascular expression of caveolin-1, which plays an essential role in both inward remodeling and hypertrophy. 154 In contrast, Ang II increases expression of MMP9, but MMP9 is only involved in inward remodeling. 154 Other molecules that have been implicated in these changes are endothelin-1, aldosterone, mineralocorticoid receptors, and chloride channels (TMEM16A).
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Vascular Distensibility
Changes in vascular stiffness or distensibility commonly occur during hypertension and aging, 165 but can be seen with other vascular risk factors as well. In hypertension, the pattern of change differs between large and small vessels. Large arteries show collagen deposition with reduced distensibility, 139, 166 whereas small vessels exhibit inward remodeling but no stiffening. 139 Importantly, both changes can contribute to reduced vasodilator capacity and thus affect CBF (Figure 3 ). With aging, loss of elastin and vascular muscle occur with a resulting reduction in arteriolar distensibility, changes that also contribute to impaired vasodilation. 148 A similar loss of elastin and vascular muscle has been described in cerebral arteries in subjects with Alzheimer disease. 136 In the absence of hypertension, mutations in Notch3 that cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, the most common known genetic cause of SVD, also produces reductions in arterial distensibility. 167 
Vascular Rarefaction
Rarefaction represents the loss of vessels, commonly capillaries and arterioles, within a vascular bed (Figure 3) . A reduction in vascular density in these segments can occur with disease and in response to genetic factors or stimuli that impact vessel destruction or angiogenesis. In models of hypertension, for example, there is loss of brain arterioles and capillaries. 168 Similar reductions in microvascular density are seen in humans with essential hypertension. 157, 159 The vascular degeneration that has been described in small arteries and arterioles would contribute to this process as well. 137 Preclinical models of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy exhibit age-dependent reductions in capillary density and CBF. 42, 169 Collateral Vessels Collateral vessels are connections between arteries or between arterioles in the microcirculation. In patients and preclinical models, the structural and functional status of collateral vessels determines the extent of cellular injury and death after occlusion of supply arteries upstream. 170, 171 This segment of the vasculature contributes to maintenance of CBF during ischemic challenges, reductions in perfusion pressure, or loss of autoregulation. The status of collaterals may also impact the outcome of vascular-based stroke therapies. Their location, number, and diameter determine the effectiveness of collaterals. The collateral network within the pial circulation is extensive. 172 In contrast, penetrating arterioles within the parenchyma often travel long distances with few branches. 7, 135, 173 Faber and others have provided recent insight into collateral size and numbers as well as the impact of genetics, vascular risk factors, and aging on the pial collateral network. 170, 172 Hypertension produces a progressive loss of collaterals (both vessel size and diameter) in the pial circulation. These changes occur much earlier than the loss of collaterals that occurs normally with aging. 170, 172 In addition, models of metabolic syndrome and leptin deficiency (used as a model of obesity) exhibit similar changes. 172 Vascular changes of this magnitude substantially increase resistance of collateral vessels and are associated with increased infarct size in models of ischemia. 170, 172 One of the normal functions of eNOS-derived NO is maintenance of vascular collaterals. 170, 172 Loss of this protective molecule seems to account for rarefaction of collaterals in the pial circulation in the face of vascular risk factors. 170, 172 In contrast to efforts toward defining structural changes, little has been done related to understanding mechanisms that control vascular tone in cerebral collaterals. A recent study found that myogenic tone and reactivity are different in collateral versus noncollateral arterioles. 174 During hypertension, for example, collaterals have increased tone and impaired vasodilation, which may result in lower levels of collateraldependent blood flow, contributing to greater infarct size in response to ischemia.
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Part II. Neurovascular Injury and Repair
After Ischemic Stroke
Our current understanding of the mechanisms of brain injury after ischemia and I/R and repair include multicellular interactions, involving the BBB, activation of glia, immune cell infiltration, and neuronal death. In contrast to the more traditional neurocentric view, recent studies emphasize the contribution of non-neuronal components of the NVU to brain injury and repair after stroke. This section highlights recent progress in our understanding of the cellular and molecular mechanisms underlying vascular injury and repair after ischemic stroke.
Effects of Ischemia on the Regulation of CBF
Ischemic-induced injury affects regulation of CBF and integrity and function of the BBB. Insight into these effects and the importance of preserving vascular function after stroke has begun to emerge. Here, we summarize select effects of ischemia (and I/R) on the vasculature.
Endothelial Function
Early work in this area revealed that global I/R impairs endothelium-dependent regulation of vascular tone, [175] [176] [177] with some evidence implicating ROS as mediators of dysfunction. 177 Other preclinical studies found that focal I/R impairs both basal and receptor-mediated endothelium-dependent vasodilation. 34, [178] [179] [180] [181] Impaired NO-mediated responses occurred despite an increase in eNOS expression after ischemia. 182 Mechanistically, these effects were because of scavenging of NO by superoxide as treatment with superoxide dismutase or related mimetics normalize vascular responses after ischemia. 180 The finding that the influence of NO on vascular tone was not impaired after ischemia in Nox2-deficient mice indicates that Nox plays a key role. 180 Interest in this area has now extended to parenchymal arterioles. Similar to findings in large arteries, the influence of endothelium-derived NO on vascular tone is impaired in parenchymal arterioles after ischemia.
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Neurovascular Coupling
Both global and focal ischemia impairs NVC in preclinical models. 181, 184, 185 For example, glucose utilization and the increase in CBF with somatosensory activation is decreased after global I/R. 186 As neural activity recovers after reperfusion, these findings suggest that communication between neurons and the vasculature is impaired after ischemic injury. In contrast, there may be a generalized and more sustained suppression of brain function in addition to impaired NVC after permanent focal ischemia in regions remote from the infarct. 187 There is currently limited insight into mechanisms that contribute to these changes. Vascular responses to direct activation of vascular muscle were not affected by I/R, suggesting communication between cells is impaired, not dysfunction of smooth muscle per se. 181 Interestingly, impaired NVC after focal I/R is prevented by lipopolysaccharide-induced ischemic tolerance. 181 This protection is dependent on iNOS-and Nox2-derived peroxynitrite. 181 Another study suggested that decreased function of inward rectifier K + channels mediate impaired NVC after global I/R.
188
Autoregulation
Ischemic injury has heterogeneous effects on the ability of the vasculature to respond the changes in perfusion pressure. Both myogenic tone and myogenic reactivity are reduced in cerebral arteries after I/R, 34, [188] [189] [190] [191] but are not sex dependent. 178 Mechanisms that contribute to impaired myogenic tone include oxidative and nitrosative stress. The content of F-actin is reduced in cerebral arteries after ischemia, an effect that was dependent on formation of peroxynitrite. 189, 190, 192 In contrast to arteries upstream, basal tone and myogenic reactivity are intact 34, 183, 193 or elevated 47 after I/R in parenchymal arterioles. This effect may be because of changes in calcium sensitivity and activation of ROCK. 47 The preservation or increase in myogenic tone in parenchymal arterioles after ischemia would be predicted to offset potential increases in CBF that would occur as a result of decreased myogenic tone of larger arteries upstream. Compromised CBF may lead to an expansion of brain injury and cell death.
In vivo studies in this area are generally consistent with studies of isolated vessels. When hypotension was induced during or after global ischemia, CBF was significantly reduced, an effect that was not observed during nonischemic conditions. 194 Focal ischemia impairs autoregulation to both hypotension and hypertension with CBF passively after changes in arterial pressure. 195 Autoregulation was also impaired in areas of milder ischemia; with persistent effects 24 hours post-injury. 195, 196 
Structural Injury and Repair of Microvascular Components Within the Neurovascular Unit
At the level of the NVU, endothelial cells and pericytes form the basic structure of the BBB. BBB damage is one of the most disabling consequences of stroke. Loss of BBB integrity after ischemia permits penetration of intravascular proteins, fluid, and immune cells into the extracellular space, resulting in vasoactive edema and expansion of tissue damage. 197 Severity of BBB damage predicts neurological outcome after stroke. 198 Although it is well accepted that BBB disruption occurs early after ischemia, the exact temporal profile remains vague. Some studies reported a monophasic BBB leakage, starting as early as 25 minutes after post-ischemic reperfusion and lasting for 5 weeks. 199, 200 In other studies, a biphasic increase of BBB permeability was observed, with the first peak occurring within hours and the second peak 2 to 3 days after stroke. 201, 202 These discrepancies may be because of differences in stroke models or experimental conditions. Nevertheless, structural alterations in endothelial cells or pericytes are consistently regarded as the mechanisms underlying early BBB leakage.
Endothelium Is At the Center for Neurovascular Injury and Repair After Ischemia
Cerebral endothelial cells are the foundation of the BBB. They are specialized nonfenestrated cells sealed by highly restrictive TJs. Intact endothelium plays a critical role in controlling the exchange of ions, molecules and cells between the central nervous system and the periphery. Structural changes in endothelial cells or related TJs are the first steps to open the BBB after ischemic injury.
Cytoskeletal Rearrangement in Endothelial Cells: Opening of Paracellular Pathways Early After Stroke
Cerebral I/R rapidly initiates vascular changes including increases in paracellular permeability. Such early stage hyperpermeability is usually not accompanied by overt injury or detachment of endothelial cells from the vessel wall. Instead, it reflects more subtle changes, loosening of the endothelial paracellular junctions. 203 Structurally, the interface of adjacent endothelial cells is fused together by intercellular junctions, including TJ and adherens junctions. Both junctions are highly specialized protein complexes. The main components of the TJ complex (occludin and claudin) and the junctional adhesion molecules, are anchored to the actin cytoskeleton through TJ accessory or anchoring proteins (zonula occluden-1, zonula occluden-2, zonula occluden-3). 204 Cadherin, the main component of adherens junctions, is also stabilized by connections to actin filaments. 205 The dynamic interaction between actin February 3, 2017 cytoskeleton and junctional proteins is critical for regulation of junctional integrity and endothelial permeability. In normal conditions, actin filaments are distributed throughout endothelial cells as short filaments of F-actin at the cell marginal band (cortical actin). 206, 207 F-actin functions to sustain the shape of endothelial cells and maintain the integrity of TJ. 208 In response to certain stressors, the actin filaments are polymerized into linear stress fibers. This polymerization is often accompanied by actomyosin contraction and increased cytoskeletal tension, which result in a contracted cell morphology and impaired junctional sealing efficiency. [209] [210] [211] [212] Such cytoskeletal rearrangement results in increased permeability and BBB leakage.
Several signaling events are important in the regulation of actin dynamics (Figure 4) . Among them, phosphorylation of myosin light chains (MLC) is critical for actin-myosin contraction and disruption of endothelial cell-cell junctions. MLC is phosphorylated by MLC kinase in a Ca 2+ /calmodulin-dependent manner. RhoA, a small GTPase, and its downstream effector ROCK also potentiate MLC phosphorylation by either direct action or inhibition of MLC phosphatase activity. 213 In addition, RhoA is involved in the signaling pathway that controls actin stress fiber formation. 214 A variety of I/R related factors, including hypoxia, ROS, and cytokines, contribute to the disarrangement of cytoskeletal and junctional proteins in brain endothelial cells by activating MLC signaling. 209, 210, 212, 215 It has been recently reported that early BBB disruption after ischemia was caused by the activation of ROCK/MLC signaling, which was accompanied by persistent actin polymerization and disassembly of junctional proteins within endothelial cells. 216 This study suggests that cytoskeleton rearrangement and structural alterations in endothelial cells are a novel mechanism for early BBB disruption after stroke, which in turn contributes to late stage MMP-dependent BBB opening. More importantly, early in the disease process, BBB dysfunction may be a cause rather than a consequence of parenchymal cell injury. Therefore, stabilizing endothelial cell structure may represent an overlooked therapeutic opportunity to target the early disturbance in BBB integrity and to prevent subsequent adverse events after stroke.
Recent work has highlighted the importance of cofilin/ actin-depolymerizing factor (ADF) proteins in stabilizing endothelial structure by regulating actin dynamics (Figure 4) . The binding of activated ADF or cofilin proteins to actin filaments results in actin depolymerization, reduced stress fiber formation, stabilized endothelial structure, and maintained BBB integrity. 210, 217 Both cofilin and ADF are activated when dephosphorylated. LIM kinase and testicular protein kinase 1 are 2 molecules that phosphorylate cofilin/ADF at Ser-3 in a ROCK-dependent or ROCK-independent manner, respectively, which leads to cofilin/ADF inactivation, microtubule destabilization and actin polymerization. [218] [219] [220] However, controversial evidence suggested hyperactive cofilin may produce loss of BBB integrity by disassembling F-actin, decreasing the expression of TJ proteins 221, 222 or redistributing actin and TJ proteins. 218, 223 Such an apparent discrepancy may be attributed to the differences in the sources of endothelial cells and the dynamic changes of endothelial structure under different challenges. In the case of brain ischemia, overexpression of constitutively active ADF in endothelial cells reduces actin polymerization and junctional protein disassembly, attenuates early BBB leakage, and improves long-term histological and neurological outcomes. By contrast, ADF inactivation led to sustained actin polymerization and junctional disruption in endothelial cells. Therefore, maintaining BBB integrity might be achieved by targeting ADF activity early after stroke.
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Transcytosis: Another Mechanism for BBB Leakage After Ischemia During transcytosis, vesicles containing various cargo molecules are trafficked across the interior of a cell. 224 A recent study reported that the early increase of BBB permeability after stroke is because of increased transcytosis in endothelial cells. Interestingly, in contrast to the concept of cytoskeletal rearrangement-mediated early BBB damage, upregulation of transcellular pathways preceded the opening of paracellular pathways ( Figure 4) . 46 Increased transcytotic vesicles were observed in endothelial cells as early as 6 hours post-stroke, whereas the paracellular pathways of the BBB were not impaired until 48 hours after stroke. This observation is consistent with previous reports, 225 including the demonstration of increased vesicles in the endothelial cells in the peri-infarct cortex at 3 hours post-ischemia in both aged and young mice. 226 A study in diabetic mice also suggested that loss of BBB integrity after stroke is primarily attributed to increased transcytosis. 227 The debate about the importance of transcellular and paracellular pathway for BBB leakage is centered at the function of caveolin-1. Caveolae, membrane microdomains formed within the plasma membrane, are the main organelles in transcytosis. Caveolin is a group of proteins that play key roles in plasma membrane invagination and caveolae formation. 224 Among the family of caveolins, caveolin-1 is mainly distributed in endothelial cells and is known to be important in the regulation of BBB permeability. 224 The expression of caveolin-1 and transendothelial vesicles increases before the disruption of TJ and BBB integrity. 228, 229 Further studies showed that transcellular but not paracellular permeability of cortical blood vessels was ameliorated early after stroke in caveolin-1-deficient mice, suggesting that caveolin-1 is involved in transcellular endothelial leakage in response to stroke. 46 However, both in vivo and in vitro data obtained by another group suggested that caveolin-1-mediated transcellular mechanisms do not play a dominant role in BBB disruption up to 24 hours after ischemia, disagreeing with the contribution of transcytosis in early BBB damage after stroke. 216 Such discrepancy may be explained by differences in the severity of ischemia or possibly genetic background. Interestingly, caveolin-1 also interacts with TJ proteins to influence intercellular transport under stroke and inflammation conditions. 230, 231 It is therefore possible that the 2 biological mechanisms regulating transcellular and paracellular barrier properties are interconnected. Further studies are required to define the relative importance of transcellular and paracellular pathways and their temporal sequence in early BBB dysfunction after stroke.
Pericytes: Versatile Players in Ischemia and Reperfusion
Pericytes are components of the NVU located on the abluminal aspect of endothelial cells, sandwiched between astrocytes and endothelium and almost entirely embedded within the basal lamina. 232 As constituents of the BBB, pericytes not only exert barrier function themselves but also influence physiological functions of endothelial cells, basal lamina, and astrocytes. 233 Pericytes also possess immunologic functions, contributing to immune responses. 234 In addition, pericytes may differentiate into other cell types and thus may be important for central nervous system renewal. 235 Pericytes are early responders to brain hypoxia. After ischemic stroke, pericytes change from a quiescent flat shape into an ameboid morphology, while expressing specific proteins such as RGS5. Pericytes detach from the basal lamina as early as 1 hour after ischemic stroke, 236 followed by the migration toward the hypoperfusion lesion. 237 Detachment and migration of pericytes are associated with their secretion of MMPs. Pericytes have been shown to be an important source of MMP9 in basal lamina after ischemic stroke. 238 The chemotactic factors controlling pericyte migration are not well characterized. Hypoperfusion in the periinfarct area can induce pericyte migration. Hypoxia-induced vascular endothelial growth factor (VEGF) expression can also stimulate pericyte migration in a concentration-dependent manner. 239 After arriving at the site of injury, pericytes display both beneficial and detrimental functions during I/R and contribute significantly to BBB damage and repair ( Figure 5 ).
Impact of Contractile Pericytes on Capillary Blood Flow
Recent studies have highlighted possible roles for pericytes in regulation of capillary perfusion. However, some concepts that have arisen are controversial. 22, 29, 30, 240 After ischemic stroke, hypoperfusion resulting from vascular occlusion leads to tissue damage. Reflow of occluded vessels is crucial for tissue preservation and restoration. However, the absence of reflow in the microvasculature is common, impeding reperfusion of ischemic tissue. Contraction and relaxation of pericytes may contribute to control of capillary blood flow. 29, 241 The lack of oxygen after ischemia promptly induces relaxation of pericytes that may help dilate blocked vessels and restore CBF. Multiple mediators including platelet-derived growth factor (PDGF)-β, adenosine, and NO have been identified as potential regulators of pericyte contractility after stroke. 29, 242 For example, PDGF-β affects contractility of pericytes depending on metabolic status. 242 In particular, PDGF-β contracts pericytes when the circulation is normal and relaxes pericytes during hypoperfusion. Higher levels of PDGF-β are evident after stroke. Increased PDGF-β after ischemia relaxes pericytes, increases microvessel diameter, and elevates blood supply in the microcirculation. Other studies suggest pericytes contract after ischemia because of a reduced energy supply and may subsequently die in a contracted state. 29, 241 Thus, even with recanalization after ischemia, hypoperfusion may persist if red blood cells are unable to pass through capillaries because of constriction of pericytes and plugging by microthrombi (or immune cells).
Mechanistically, roles for excitotoxicity or oxidative or nitrosative stress in post-ischemic pericyte-induced contraction have been proposed. 29, 241 In support of an ROS-dependent mechanism, hydrogen peroxide and radiation-induced February 3, 2017 production of ROS cause contraction of cultured pericytes. 243 The precise mechanism(s) underlying oxidative stress-induced pericyte contraction is unclear. Possible mechanisms involve excessive calcium influx during reperfusion and inactivation of potassium channels or sodium/hydrogen exchangers. 241 In short, pericyte contractility may vary at different stages of I/R, potentially impacting capillary perfusion and stroke outcome.
In contrast to the aforementioned studies, Hill et al 30 provided evidence against a role for pericytes in regulating capillary perfusion in ischemic brain. Based on several lines of evidence, they concluded that parenchymal arterioles are the final point in the vasculature where CBF can be modulated and it is constriction of vascular muscle in arterioles that causes hypoperfusion during ischemia. 30 This concept is consistent with the findings of maintained or increased myogenic tone in isolated parenchymal arterioles after ischemia. 34, 47, 183, 193 Despite uncertainty on the role of pericytes in regulating capillary perfusion, this remains a potentially important area of research. Direct evidence on the influence of pericytes on capillary perfusion in vivo is still limited. Pericytes are difficult to study in vivo because of heterogeneity along with a lack of selective molecular markers 240, 244 or cell-specific promoters.
Pericytes Protect Adjacent Cells Against Ischemic Injury
Pericytes may express a variety of factors in response to ischemia that protect adjacent cells, including neurons and other NVU components. For example, ischemia induces PDGF-β expression by endothelial cells and PDGFR-β expression by pericytes. 242 Increased PDGF-β may protect pericytes from apoptosis and promote pericyte proliferation. PDGF-β also enhances the expression of neuroprotective factors including nerve growth factor and neurotrophin-3 in pericytes. Moreover, increased pericyte production of NT3 activates astrocytes and raises astrocytic secretion of nerve growth factor. 245 In addition to neuronal protection, pericytes may protect the BBB at several levels including TJ integrity, protecting endothelial cells from necrosis, and promoting angiogenesis in the ischemic brain. Pericyte-produced angiopoietin fortifies Figure 5 . Pericytes play multifaceted roles in ischemia and reperfusion. Pericytes display both beneficial and detrimental functions during ischemia and reperfusion phases, and contribute significantly to the blood-brain barrier damage and repair. 1. Pericyte contraction and dilation regulate cerebral blood flow in the ischemic and perilesion areas. 2. Pericyte protects other neurovascular unit (NVU) components through releasing protective/trophic factors such as nerve growth factor (NGF), neurotrophin-3 (NT-3), vascular endothelial growth factor (VEGF), angiopoietin (Ang-1), and glial cell line-derived neurotrophic factor (GDNF). 3. Phagocytotic pericytes help to eliminate dead or injured tissue in the ischemic core, which in turn mitigates local inflammation and reduce secondary tissue damage. 4. Pericyte-endothelial cell interaction promotes angiogenesis after stroke. 5) Pericytes have the potential to serve as an origin of NVU components during tissue repair after ischemic stroke. Illustration credit: Ben Smith.
TJ connections by enhancing the expression of TJ proteins including zonula occluden-1. 246 Glial cell line-derived neurotrophic factor produced by pericytes upregulates the expression of claudin-5 in endothelium, promoting integrity of the BBB. 247 In addition, pericyte-derived VEGF can enhance survival of endothelial cells and preserve their function in ischemic stroke. 248 Pericytes can also secrete transforming growth factor-β1, which enhances VEGF receptor 1 expression on endothelial cells and may improve endothelial survival in ischemia. Overall, the interactions of pericytes with endothelial cells, neurons, and astrocytes support the preservation and reconstruction of the NVU after cerebral ischemia. 249, 250 Phagocytotic Pericytes Clear Cell Debris After Stroke Electron microscopy suggests that there are 2 types of brain pericytes: granular and filamentous. 251 These subtypes can be distinguished based on the presence of cytoplasmic lysosomelike granules. 252 Pericytes containing lysosome-like granules can serve as scavenger cells in injured brain. In an animal model of ischemia where human atheroma samples were injected intravascularly, an increase in granular pericytes was detected in the injured brain area as early as 2 hours after injection. Moreover, these granular pericytes accumulated lipid components of the injected atheroma, 253 suggesting a phagocytotic property of granular pericytes. With the capacity of multipotent differentiation, pericytes can also acquire microglia phenotype after ischemia. 254, 255 These phagocytotic pericytes and microglia derived from multipotent pericytes may help to eliminate dead and injured tissue in the ischemic core, which in turn mitigates local inflammation and reduces secondary tissue damage.
Production of ROS by Pericytes After Stroke
In addition to the aforementioned beneficial effects, pericytes may release detrimental factors in response to ischemia. In particular, hypoxic stress induces ROS production by pericytes. Nox4 is a major source of ROS in human brain pericytes.
256
Nox4 is upregulated in pericytes after acute ischemia in periinfarct areas and enhances BBB leakage by activating nuclear factor-κB and MMP9 production. 257 The upregulation of Nox4 is greater in permanent than in transient focal ischemia, suggesting that ischemia is a strong inducer for Nox4 and subsequent ROS production in pericytes. The increased level of ROS causes detrimental effects in other already compromised cells within the NVU. Pericytes themselves are sensitive to low concentrations of ROS and may be more fragile than endothelial cells. Apoptosis of pericytes was evident in ischemic areas after reperfusion, when production of ROS was elevated. Antioxidative treatment inhibited pericyte death after I/R, 243 suggesting a key role for ROS in the demise of pericytes. 29 Overall, pericytes are much more than supportive cells to endothelium. They have vital functions within the BBB and NVU. Pericytes display morphological and functional alterations during ischemia and reperfusion and may be involved in multiple processes after stroke.
Pericyte-Endothelial Interactions in Angiogenesis and Neovascularization
A neurovascular regenerative program is activated after stroke as a mechanism of brain repair. The capacity of such neurovascular repair is critical for long-term recovery after stroke. Angiogenesis, or the growth of new blood vessels, is an important component of BBB remodeling. In addition to its potential to re-establish the blood supply to hypoperfused areas, early upregulation of angiogenic factors including VEGF and angiopoietin can promote cell survival and enhance the removal of cell debris. 258 Interestingly, 1 study suggested that angiogenic responses were transiently activated after stroke to enhance macrophage infiltration and debris clearance, rather than increasing microvessel density. 258 Such a cleanup-alone hypothesis is challenged, however, by a large number of animal and human studies, showing positive effects of angiogenesis on post-stroke functional recovery. 259, 260 Further investigations are warranted to confirm the causal relationship between angiogenesis and functional improvement after stroke.
The processes of angiogenesis include proliferation of vessel cells, recruitment of pericytes, coverage of endothelial tubes by pericytes, and maturation of newly formed vessels. Endothelial cells, pericytes, and the communication between these cells are essential for the regulation of angiogenesis. 261 Endothelial cells start to proliferate and grow vessel sprouts within 1 day after brain ischemia, leading to formation of new vessels in the peri-infarct region several days after ischemic injury. 262, 263 Meanwhile, pericytes with upregulated PDGFR-β start to proliferate and migrate from the microvessel wall to the new vessel sprouts to foster their maturation. 261 Administration of a phosphodiesterase-3 inhibitor that promotes pericyte proliferation decreased the final infarct size by enhancing new vessel formation after stroke in hypertensive rats. 264 In contrast, post-stroke angiogenesis was impaired in hyperlipidemic or diabetic mice with pericyte dysfunction and weakened pericyte-endothelial cell communication. 249, 259 A recent study found that injection of blood-derived pericyte-like cells could rescue affected tissue by accelerating angiogenesis in a model of hindlimb ischemia. 265 This result indicates that transplantation of pericyte progenitor cells may be a promising therapy for ischemia and could be possibly applied in ischemic stroke. More intriguingly, pericytes isolated from the ischemic regions of mouse or human brains reveal mesenchymal multilineage developmental properties when cultured under oxygen/ glucose depriving environment, and could differentiate into both neural and vascular lineage cells. 266 Therefore, pericytes may have the potential to serve as an origin of NVU components during tissue repair after ischemic stroke.
Despite the potential beneficial effects of angiogenesis in post-stroke recovery, the elevation of angiogenic factors such as VEGF may increase vascular permeability and in turn contribute to edema or hemorrhage. 267 A thorough understanding of the dynamics and mechanisms of angiogenesis is essential for developing an effective therapy for stroke.
Inflammation in BBB Disruption After Ischemia and Reperfusion
Neurovascular inflammation involves a complex interaction between endothelial cells, resident microglia, and invading leukocytes and plays a critical role in BBB disruption after I/R. Cerebral I/R triggers expression and release of inflammatory mediators and proteases from endothelium and immune cells and causes BBB disruption. 268 These destructive factors include (1) MMPs that degrade the extracellular matrix; (2) chemokines, such as monocyte chemoattractant-1, February 3, 2017 that attract peripheral leukocytes; (3) adhesive molecules, such as selectins and intercellular adhesion molecule that enhance leukocyte-endothelial cell interaction; and (4) inflammatory cytokines that exacerbate inflammatory injury to components of the NVU. Meanwhile, local microglia are recruited to ischemic sites, where they secrete immune mediators and further activate endothelial cells, leading to BBB breakdown. In addition, the primed BBB permits the extravasation of neutrophils, monocytes, and other peripheral immune cells, which carry with them even more deleterious inflammatory mediators. Microvascular accumulation of these immune cells, proinflammatory mediators, and proteases not only potentiate junctional disassembly and endothelial malfunction but also degrade the extracellular matrix, resulting in irreversible BBB disruption. In this section, we focus on current concepts regarding the function of MMPs and effects of several immune cell populations in NVU injury and repair after ischemia.
MMPs in BBB Disruption After Ischemia and Reperfusion
MMPs are a family of proteins specialized in the degradation of extracellular matrix and basement membrane. MMP2 and MMP9 can be released from a variety of cells including endothelial cells, glial cells, and recruited immune cells. 269 Both these MMPs are strongly implicated in the disruption of the BBB after ischemic injury in both rodent models 230, 270 and patients with stroke. 271 Genetic ablation or pharmacological inhibition of MMP2/9 provides protection on BBB integrity and reduces brain damage after I/R. 230, 270 Interestingly, recent studies demonstrated that the increase of brain MMP2/9 seems to be relatively delayed compare to the early loss of BBB integrity. 216 The BBB becomes permeable to smaller molecules (≤10 kDa) very early (30 minutes) after cerebral I/R. In contrast, active MMP9 and MMP2 were observed in the ischemic brain beginning at 3 hours after focal ischemia, progressively increasing over the course of 24 hours. 272 In vitro studies suggest that the inhibition of MMP2/9 activity greatly reduced changes in endothelial permeability at 4 to 6 hours after oxygen-glucose deprivation, but failed to protect the early breach of endothelial cell integrity at 1 to 3 hours after oxygen-glucose deprivation. In vivo animal studies showed that MMP2 or MMP9 knockout or inhibition can prevent BBB leakage of larger molecules (>40 kDa) at 3 or 24 hours after focal ischemia but failed to reduce the leakage of smaller molecules, suggesting that MMP2/9 contributes to severe BBB disruption after I/R in a relatively delayed manner. Notably, MMP2/9 ablation transiently reduced infarct volume at 24 hours after focal ischemia but failed to provide longterm protection. 216 These data suggest that MMPs may represent a target for BBB protection after I/R; however, inhibiting MMPs alone is not sufficient to provide early and prolonged protection to the BBB or the ischemic brain.
It should be noted that MMPs are not always detrimental in ischemia as they serve critical functions related to stroke recovery and NVU remodeling. 273 Treatment with MMP inhibitors 7 days after stroke increases ischemic brain injury and impairs functional recovery at 14 days. Bioprocessing of VEGF by MMP-9 was proposed as one of the underlying mechanisms of neurovascular remodeling after cerebral ischemia. 274 Considering the dual role of MMPs at different phases after cerebral ischemia, timing is an important factor to be considered for therapeutic strategies targeting MMPs.
Neutrophils: A Key Player in Early BBB Disruption
Neutrophils migrate toward the injured brain within a few hours after stroke onset in response to the upregulation of adhesion molecules, such as intercellular adhesion molecule -1 and P-selectin, on injured endothelium. 275, 276 The importance of neutrophils in post-ischemic BBB damage is confirmed by the fact that inhibition or depletion of neutrophils mitigated BBB leakage after stroke and reduced the risk of hemorrhagic transformation after thrombolysis. 277, 278 In contrast, triggering neutrophil activation with lipopolysaccharide greatly enhances BBB disruption in a rodent model of stroke. 279 Neutrophils greatly contribute to BBB disruption through the release of a variety of proteases, including MMPs, elastase, cathepsin G, and proteinase 3.
278,280-282 Neutrophils are major sources of MMP9, so their infiltration into the ischemic brain enhances central MMP9 levels by releasing the MMP9 proform. 280, 283 Reperfusion after tissue-type plasminogen activator treatment promotes the degranulation of human neutrophils and release of MMP9. 284 Clinical data revealed that MMP9-positive neutrophil infiltration is associated with BBB breakdown, basal lamina type IV collagen degradation, and hemorrhagic transformation. 271 In addition to MMP9, neutrophil elastase is involved in BBB breakdown by degrading basal lamina and extracellular matrix. Accordingly, pharmacological inhibition or genetic ablation of neutrophil elastase reduced BBB damage and decreased cerebral edema. 285, 286 Furthermore, inhibition of elastase in MMP9-deficient mice further decreased infarct volume and BBB disruption, suggesting that the contribution of neutrophil elastase and MMP9 to BBB damage is independent of each other. 286 A therapeutic strategy with the capacity to inhibit both MMP9 and elastase may be more effective than targeting either of them individually.
Neutrophils are also important sources of ROS after I/R. 287, 288 ROS disrupts the NVU through damage to multiple components including endothelium, pericytes, smooth muscle, neurons, and astrocytes. These effects result in increased BBB permeability and hemorrhagic transformation. Superoxide is one of the most important mediators of BBB damage during reperfusion. 289 Neutrophils express high levels of Nox, a major source of superoxide. Inhibition or depletion of Nox reduces the degree of neutrophil infiltration, which is accompanied by ameliorated BBB disruption and reduced infarct volume. 290, 291 Finally, neutrophils in the microvasculature may physically obstruct capillaries contributing to no-reflow during reperfusion. 292 Therefore, inhibition of neutrophil adherence to endothelial cells may promote the microvascular patency by reducing the no-reflow phenomenon in regions affected by I/R.
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Microglia/Macrophage Polarization Influences BBB Injury and Repair
Recent studies highlighted the importance of microglia/macrophages phenotypes in brain injury and repair. On activation, microglia/macrophages can develop into a spectrum of different but overlapping functional phenotypes. The classically activated M1 phenotype and the alternatively activated M2 phenotype represent 2 ends of this spectrum, with a variety of phenotypes in between. M1-like microglia/macrophages are generally characterized by the release of destructive proinflammatory mediators. In contrast, M2-like microglia/macrophages typically release protective/trophic factors to preserve brain tissue or promote brain repair. 294 Accumulating studies have documented the distinct functions of M1-like and M2-like microglia/macrophage in the BBB injury and repair, suggesting a possible therapeutic strategy to promote NVU integrity by modulating the phenotypic balance within these cell types.
Microglia/Macrophage Polarity in BBB Injury
After Ischemic Stroke Activated M1 phenotype microglia may play a detrimental role in BBB integrity by eliciting the expression of proinflammatory cytokines such as interleukin-1β, interleukin-6, and tumor necrosis factor-α. Several M1 cytokines contribute to BBB damage after stroke. Interactions of tumor necrosis factor-α with endothelial cells increase the paracellular permeability of the BBB by altering cytoskeletal organization and TJ expression and promoting production of MMPs. 295 The upregulation of interleukin-1β after ischemia could induce endothelial expression of adhesion molecules, including intercellular adhesion molecule -1 and vascular cell adhesion molecule-1, which in turn promotes neutrophil and other immune cell adhesion and infiltration into sites of injury. 296 The M2 phenotype microglia, in contrast, enhance BBB integrity by increasing TJ expression after stroke.
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Effect of Microglia/Macrophage Polarity in Post-Stroke Angiogenesis and Brain Repair Studies of vascular repair during wound healing have suggested phenotype-specific roles for macrophage in angiogenesis. 298, 299 M2 macrophages are proangiogenic by releasing VEGF, 300 interleukin-8, 298 and a unique tissue inhibitor of metalloproteinases-1 free form of pro-MMP9. 299 The influence of microglial phenotype on angiogenesis, however, has not been well addressed. Nevertheless, the activation state of microglia has been shown to regulate brain endothelial cell proliferation. 297 Specifically, the M1-type cytokine tumor necrosis factor-α and the M2-type cytokine transforming growth factor-β exhibit distinct effects on the proliferation of endothelial cells. Furthermore, minocycline and some other experimental treatments potentiate microglia/macrophage M2 polarization while promoting angiogenesis or BBB remodeling after stroke. [301] [302] [303] These studies suggest that the polarization state of microglia/macrophage might be a key regulator of angiogenesis and BBB repair after stroke.
Interestingly, the phenotypic diversity described above is not restricted to microglia/macrophages. Neutrophils also exhibit N1 and N2 phenotypes in ischemic brain, with N2 polarization being associated with resolution of inflammation. 304 Such differential effects of distinct immune cell phenotypes on NVU injury and repair need to be further investigated.
Risk Factors for NVU Integrity After Ischemic Stroke
The effects of aging on vascular components of the NVU and their response to ischemia are evident. First, aging reduces endothelium-dependent regulation of vascular tone, 17 ,22,77 the regenerative capacity of endothelial cells, 305 and the number of circulating endothelial progenitor cells. 306 Second, associations between pericytes and capillaries are reduced with aging. 307, 308 Third, age-related alterations in microglial function are prominent making them less mobile and less efficient in central nervous system surveillance. 309 Aged microglia tend to polarize into an M1 phenotype, 310, 311 which may impair their function in NVU repair. Finally, the function of other NVU components, including astrocytes, oligodendrocytes, and neurons, is each compromised with aging. 312 These structural and functional changes likely increase vulnerability to stroke and enhance ischemic brain injury in the elderly. 313, 314 Other vascular risk factors, including hyperlipidemia, diabetes mellitus, and hypertension enhance BBB damage after ischemia. 315, 316 Increased lipid peroxidation, elevated protease activity, downregulation of TJ expression, and increased inflammation are potential mechanisms for dyslipidemiaenhanced BBB damage. 315, 317 Hypertension is associated with disorganization of TJs, BBB dysfunction, and cerebral edema. 318 Diabetes mellitus also exacerbates BBB damage in different neurological disorders. Specifically, fluctuations in plasma glucose levels are associated with altered BBB transport, impaired TJ integrity, and elevated oxidative stress. 319 Hyperglycemia exacerbates inflammatory responses, such as cytokine expression and neutrophil infiltration, 320 in the NVU. Consequently, vascular injury in response to ischemia is increased in diabetes. 321 In addition to endothelium and pericytes, other components of the NVU can be affected by vascular risk factors and ischemia. For example, hypertension produces focal swelling and other changes in astrocyte end feet around capillaries, 251, 318 changes that likely contribute to loss of BBB integrity and may impact local regulation of CBF. Overall, treatment or prevention of these and other comorbidities may lessen NVU damage after ischemia and improve disease outcome.
Conclusions
In this review, we have outlined major mechanisms that regulate CBF along with features of large vessel disease and SVD that underlie ischemic events and impact their severity. Loss of endothelial health is a central player in the onset and progression of cerebrovascular disease. We highlighted common underlying mechanisms that contribute to structural and functional changes, particularly endothelial-based abnormalities. Damage to the BBB is one of the consequences of stroke with the greatest impact. How changes in endothelial TJs, the cytoskeleton, and the rate of transcytosis impact BBB integrity over time is gradually becoming clear. Protective and detrimental effects of pericytes on the BBB and other components of the NVU have begun to emerge. Finally, the molecular basis of contributions by immune cells and related factors such as MMPs has been actively investigated. A thorough mechanistic understanding of CBF regulation, vascular, and NVU injury during the formation and development of ischemic stroke should provide therapeutic strategies to preserve post-stroke vascular integrity. Investigations into the impact of leading risk factors for cerebrovascular disease, stroke, and BBB injury will provide further opportunities to prevent the occurrence of ischemic events and improve disease outcome.
